| 5-y cohorts . | ||||
|---|---|---|---|---|
| . | Endocrine therapy cohort . | Chemotherapy cohort . | ||
| . | No intervention . | Optimal uptake . | No intervention . | Optimal uptake . |
| 5-y breast cancer mortality among Black patients, % | 6.9 | 6.3 (6.1, 6.4) | 25.2 | 23.7 (23.1, 24.3) |
| 5-y breast cancer mortality among White patients, % | 3.5 | 3.2 (3.1, 3.3) | 16.6 | 15.8 (15.5, 16.1) |
| 5-y breast cancer mortality gap (Black/White), percentage points | 3.4 | 3.1 (3.0, 3.1) | 8.6 | 7.9 (7.6, 8.1) |
| 5-y cohorts . | ||||
|---|---|---|---|---|
| . | Endocrine therapy cohort . | Chemotherapy cohort . | ||
| . | No intervention . | Optimal uptake . | No intervention . | Optimal uptake . |
| 5-y breast cancer mortality among Black patients, % | 6.9 | 6.3 (6.1, 6.4) | 25.2 | 23.7 (23.1, 24.3) |
| 5-y breast cancer mortality among White patients, % | 3.5 | 3.2 (3.1, 3.3) | 16.6 | 15.8 (15.5, 16.1) |
| 5-y breast cancer mortality gap (Black/White), percentage points | 3.4 | 3.1 (3.0, 3.1) | 8.6 | 7.9 (7.6, 8.1) |
| 10-y cohorts . | ||||
|---|---|---|---|---|
| . | Endocrine therapy cohort . | Chemotherapy cohort . | ||
| . | No intervention . | Optimal uptake . | No intervention . | Optimal uptake . |
| 10-y breast cancer mortality among Black patients, % | 14.5 | 13.3 (13.1, 13.5) | 29.7 | 27.9 (27.3, 28.6) |
| 10-y breast cancer mortality among White patients, % | 7.8 | 7.2 (7.1, 7.3) | 21.5 | 20.5 (20.2, 20.9) |
| 10-y breast cancer mortality gap (Black/White), percentage points | 6.7 | 6.1 (6.0, 6.2) | 8.2 | 7.4 (7.1, 7.7) |
| 10-y cohorts . | ||||
|---|---|---|---|---|
| . | Endocrine therapy cohort . | Chemotherapy cohort . | ||
| . | No intervention . | Optimal uptake . | No intervention . | Optimal uptake . |
| 10-y breast cancer mortality among Black patients, % | 14.5 | 13.3 (13.1, 13.5) | 29.7 | 27.9 (27.3, 28.6) |
| 10-y breast cancer mortality among White patients, % | 7.8 | 7.2 (7.1, 7.3) | 21.5 | 20.5 (20.2, 20.9) |
| 10-y breast cancer mortality gap (Black/White), percentage points | 6.7 | 6.1 (6.0, 6.2) | 8.2 | 7.4 (7.1, 7.7) |
Results presented in the “No intervention” columns represent outcomes in the absence of intervention, while results in the “Optimal uptake” columns represent simulation results in a scenario in which 100% of eligible patients received adjuvant therapy. Results are presented separately for the 5-year and 10-year endocrine therapy and chemotherapy cohorts. Uncertainty bounds represent 95% of simulation results.
| 5-y cohorts . | ||||
|---|---|---|---|---|
| . | Endocrine therapy cohort . | Chemotherapy cohort . | ||
| . | No intervention . | Optimal uptake . | No intervention . | Optimal uptake . |
| 5-y breast cancer mortality among Black patients, % | 6.9 | 6.3 (6.1, 6.4) | 25.2 | 23.7 (23.1, 24.3) |
| 5-y breast cancer mortality among White patients, % | 3.5 | 3.2 (3.1, 3.3) | 16.6 | 15.8 (15.5, 16.1) |
| 5-y breast cancer mortality gap (Black/White), percentage points | 3.4 | 3.1 (3.0, 3.1) | 8.6 | 7.9 (7.6, 8.1) |
| 5-y cohorts . | ||||
|---|---|---|---|---|
| . | Endocrine therapy cohort . | Chemotherapy cohort . | ||
| . | No intervention . | Optimal uptake . | No intervention . | Optimal uptake . |
| 5-y breast cancer mortality among Black patients, % | 6.9 | 6.3 (6.1, 6.4) | 25.2 | 23.7 (23.1, 24.3) |
| 5-y breast cancer mortality among White patients, % | 3.5 | 3.2 (3.1, 3.3) | 16.6 | 15.8 (15.5, 16.1) |
| 5-y breast cancer mortality gap (Black/White), percentage points | 3.4 | 3.1 (3.0, 3.1) | 8.6 | 7.9 (7.6, 8.1) |
| 10-y cohorts . | ||||
|---|---|---|---|---|
| . | Endocrine therapy cohort . | Chemotherapy cohort . | ||
| . | No intervention . | Optimal uptake . | No intervention . | Optimal uptake . |
| 10-y breast cancer mortality among Black patients, % | 14.5 | 13.3 (13.1, 13.5) | 29.7 | 27.9 (27.3, 28.6) |
| 10-y breast cancer mortality among White patients, % | 7.8 | 7.2 (7.1, 7.3) | 21.5 | 20.5 (20.2, 20.9) |
| 10-y breast cancer mortality gap (Black/White), percentage points | 6.7 | 6.1 (6.0, 6.2) | 8.2 | 7.4 (7.1, 7.7) |
| 10-y cohorts . | ||||
|---|---|---|---|---|
| . | Endocrine therapy cohort . | Chemotherapy cohort . | ||
| . | No intervention . | Optimal uptake . | No intervention . | Optimal uptake . |
| 10-y breast cancer mortality among Black patients, % | 14.5 | 13.3 (13.1, 13.5) | 29.7 | 27.9 (27.3, 28.6) |
| 10-y breast cancer mortality among White patients, % | 7.8 | 7.2 (7.1, 7.3) | 21.5 | 20.5 (20.2, 20.9) |
| 10-y breast cancer mortality gap (Black/White), percentage points | 6.7 | 6.1 (6.0, 6.2) | 8.2 | 7.4 (7.1, 7.7) |
Results presented in the “No intervention” columns represent outcomes in the absence of intervention, while results in the “Optimal uptake” columns represent simulation results in a scenario in which 100% of eligible patients received adjuvant therapy. Results are presented separately for the 5-year and 10-year endocrine therapy and chemotherapy cohorts. Uncertainty bounds represent 95% of simulation results.
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.
